Basilea Pharmaceutica
Clinical trials sponsored by Basilea Pharmaceutica, explained in plain language.
A pharmaceutical company developing treatments for infectious diseases and cancer.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
New Pill-Form fungus fighter takes on deadly candida
Disease control Recruiting nowThis Phase 3 trial tests a new drug called fosmanogepix against standard treatments for life-threatening Candida bloodstream or organ infections. About 450 adults will be randomly assigned to receive either fosmanogepix (first by IV, then as a pill) or the usual IV caspofungin fo…
Phase: PHASE3 • Sponsor: Basilea Pharmaceutica • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New hope against deadly mold infections enters final testing
Disease control Recruiting nowThis study tests a new medicine called fosmanogepix for adults with serious mold infections that are hard to treat. About 234 people will join, receiving either the new drug or standard care. The main goal is to see if fewer people die by day 42. The study is currently recruiting…
Phase: PHASE3 • Sponsor: Basilea Pharmaceutica • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New antibiotic candidate enters first human safety trial
Disease control Recruiting nowThis early-stage trial is testing a new experimental antibiotic, BAL2420, in 136 healthy adults. The goal is to check if it is safe and how the body processes it. Researchers will give single or multiple doses and watch for side effects. This is a first step toward possibly using…
Phase: PHASE1 • Sponsor: Basilea Pharmaceutica • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New antibiotic combo tested in healthy volunteers – no cure yet
Knowledge-focused Recruiting nowThis early-stage study tests a new antibiotic combination (ceftibuten-ledaborbactam) in 46 healthy adults aged 18-55. The goal is to check safety and how the drug moves through the body, not to treat any disease. Participants will stay at a clinic for several days and have follow…
Phase: PHASE1 • Sponsor: Basilea Pharmaceutica • Aim: Knowledge-focused
Last updated Jul 11, 2026 00:00 UTC